Sunday, June 14, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 156 of 1,261
  1. US 11826327

    Treatment for interstitial lung disease

    United Therapeutics Corporation · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  2. US 11825819

    Crnn loss of function rodent model

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  3. US 11826315

    STAT3 inhibitors

    Tvardi Therapeutics, Inc. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  4. US 11819509

    Lipid compositions

    AKER BIOMARINE ANTARCTIC AS · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  5. US 11819512

    Solid forms of a CD73 inhibitor and the use thereof

    Arcus Biosciences, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  6. US 11819516

    Immunotherapy

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  7. US 11819517

    Methods of using tumor infiltrating lymphocytes in double-refractory melanoma

    Iovance Biotherapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  8. US 11819523

    Compositions and methods for C. difficile treatment

    Regents of the University of Minnesota · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  9. US 11819571

    Micelle constructs comprising curcumin

    IMMIX BIOPHARMA, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  10. US 11819572

    Treatment of pain by administration of sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  11. US 11819573

    Treatment of hip pain with sustained-release liposomal anesthetic compositions

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  12. US 11819574

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  13. US 11819575

    Manufacturing of bupivacaine multivesicular liposomes

    Pacira Pharmaceuticals, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  14. US 11820815

    Human antibodies to human delta like ligand 4

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  15. US 11820824

    Antibodies to TIGIT

    Arcus Biosciences, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  16. US 11820826

    Anti-NPR1 antibodies and uses thereof

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  17. US 11820773

    Tricyclic compounds

    Aligos Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  18. US 11820781

    Bifunctional compounds for degrading BTK via ubiquitin proteosome pathway

    NURIX THERAPEUTICS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  19. US 11820982

    Treatment of ophthalmic conditions with son of Sevenless 2 (SOS2) inhibitors

    REGENERON PHARMACEUTICALS, INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  20. US 11821008

    Liver targeting adeno-associated viral vectors

    BIOMARIN PHARMACEUTICAL INC. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  21. US 11821003

    Cardiogenic mesoderm formation regulators

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  22. US 11820870

    Photocontrolled dynamic covalent linkers for polymer networks

    Northwestern University · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  23. US 11820775

    Pyrrolopyrimidine ITK inhibitors

    Aclaris Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted
  24. US 11819554

    Compositions and methods for modulating FMR1 expression

    Fulcrum Therapeutics, Inc. · Granted Nov 21, 2023 · Expires Nov 16, 2043

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.